<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>前免疫</title><link/>https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=101560960%20%20%5BNLMID%5D&amp;utm_medium = rsss&amp;ff=20250317 205223＆utm_content = 101560960＆fc = none＆v = 2.18.0.post9+e462414＆utm_campaign =期刊＆utm_source = chrome = chrome<description>前免疫：PubMed的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=101560960%20%5BNLMID%5D&amp;utm_medium=rss&amp;ff=20250317205223&amp;utm_content=101560960&amp;fc=None&amp;v=2.18.0.post9+e462414&amp;utm_campaign=journals&amp;utm_source=Chrome" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS提要（2.18.0.post9+E462414）</generator><language> en</language><lastbuilddate>星期二，2025年3月18日00:52:24 +0000</lastbuilddate><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title>通过WGCNA和LASSO鉴定并验证了与NASH合并的COPD的免疫相关诊断指标和靶向疗法</title><link/>https://pubmed.ncbi.nlm.nih.gov/40093012/?utm_source=Chrome&amp;utm_medium = rsss＆utm_camp aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250317205223＆v = 2.18.0.post9+e462414<description>结论：通过各种生物信息学方法鉴定出COPD和NASH中的HUB基因S100A9和MYH2，并构建了诊断模型以提高诊断效率。我们还揭示了COPD和NASH的一些潜在生物学机制以及与COPD相关的NASH的潜在药物。我们的发现为COPD相关的NASH提供了潜在的新诊断和治疗选择，并可能有助于降低其患病率。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月28日； 16：1514422。 doi：10.3389/fimmu.2025.1514422。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：慢性阻塞性肺疾病（COPD）和非酒精性脂肪肝疾病（NAFLD）的发生率在过去几十年中显着增加，这带来了巨大的公共卫生负担。越来越多的研究指向COPD和NAFLD之间的联系。这项研究旨在确定这两种疾病的关键基因，构建诊断模型，并根据关键基因预测潜在的治疗剂。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：从GEO数据库中获得NAFLD和COPD数据集，通过差分分析鉴定差异基因，WGCNA构建了PPI网络并富含差异基因的PPI网络，并筛选了与COPD相关的分泌蛋白，筛选，免疫细胞渗透。同时，拉索和RF进一步筛选了必需基因，最后获得了两个关键基因。随后，基于这两个核心基因构建了nom图诊断模型和LNCRNA-MIRNA-MRNA网络，并经过药物预测和GSEA富集分析，并在外部队列中使用QRT-PCR进行了验证。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：KEGG富集分析表明NF-KAPPA B和TNF信号通路可能与COPD和NASH合并症有关。通过CMAP分析（包括Ansoprazole和Atovaquone）鉴定了与COPD和NASH相关的十种小分子药物。此外，通过机器学习方法，我们进一步确定了NAFLD和COPD的HUB基因S100A9和MYH2。免疫浸润表明，这两个核心基因可能通过调节特定免疫细胞类型的功能或募集来参与NASH的免疫调节过程。基于这两个核心基因构建了名义图诊断模型。 S100A9的AUC值为0.887，MYH2为0.877，命名图为0.889，表现出极好的诊断功效。在DGIDB数据库中搜索了针对S100A9和67 MYH2的24个潜在药物。同时，通过预测生物标志物的靶MiRNA并进一步预测靶向miRNA的LNCRNA-MIRNA-MRNA网络。 QRT-PCR分析表明，S100A9在COPD和NAFLD中均上调，与生物信息学预测一致，而MYH2在COPD中的表达增加，但在NAFLD中的表达降低，与两种疾病的预测下调不同。这些发现表明，S100A9是两种疾病的常见炎症标记，而MYH2可能受疾病特异性机制的调节，强调了其将COPD与NAFLD区分开的潜力。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：通过各种生物信息学方法鉴定出COPD和NASH中的HUB基因S100A9和MYH2，并构建了诊断模型以提高诊断效率。我们还揭示了COPD和NASH的一些潜在生物学机制以及与COPD相关的NASH的潜在药物。我们的发现为COPD相关的NASH提供了潜在的新诊断和治疗选择，并可能有助于降低其患病率。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40093012/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40093012</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11906333/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11906333</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1514422>10.3389/fimmu.2025.1514422</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40093012</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator>江港</dc:creator><dc:creator>Zikai Xu</dc:creator><dc:creator> fangrui xu</dc:creator><dc:creator>海芬·吴（Haifeng Wu）</dc:creator><dc:creator> Jinxia Liu</dc:creator><dc:creator> Lishuai Qu</dc:creator><dc:date> 2025-03-17</dc:date><dc:source>免疫学领域</dc:source><dc:title>通过WGCNA和LASSO鉴定并验证了与NASH合并的COPD的免疫相关诊断指标和靶向疗法</dc:title><dc:identifier>PMID：40093012</dc:identifier><dc:identifier> PMC：PMC11906333</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1514422</dc:identifier></item><item><title>以多为中心的临床验证证明了狼疮诊断中的精度：T细胞自身抗体和TC4D的表现要优于常规狼疮红eRythematosus生物标志物</title><link/>https://pubmed.ncbi.nlm.nih.gov/40093011/?utm_source=chrome&amp;utm_medium = rsss＆utm_camp aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250317205223＆v = 2.18.0.post9+e462414<description>结论：新型的SLE生物标志物TC4D，TigG和Tigm在多个同类中始终超过常规标记。它们的整合增强了诊断敏感性，尤其是在SLE特异性自身抗体阴性患者中的敏感性。当与常规生物标志物结合使用时，这些新型测试可能会更早，更准确地检测，从而及时诊断和治疗。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月26日； 16：1518208。 doi：10.3389/fimmu.2025.1518208。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：T细胞自身抗体，TIGG和TIGM，以及T细胞结合的补体蛋白片段C4D（TC4D）是新型的诊断生物标志物，对SLE表现出很高的特异性和敏感性。本研究旨在表征多中心临床验证队列中新兴T细胞生物标志物的临床性能特征。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：由400名成年患者组成的3个学术和2名基于社区的自身免疫性风湿中心，由105名SLE患者组成，有173例自身免疫性风湿病患者（ARD），83名显然健康的志愿者（AHV）和39个（非释放）疾病（非释放）疾病（odig）and test and Tcm test tc4 tc4 tc4自身抗体概况。针对ARD，AHV和OD组评估了诊断特异性。半定量流式细胞仪分析包括TIGG和TIGM自身抗体，细胞结合的补体激活产物（CB-CAPS），TC4D，红细胞结合C4D（EC4D）和B淋巴细胞结合的C4D（BC4D）。常规自身抗体和可溶性补体蛋白C3和C4分别通过ELISA和免疫尿路次次法评估。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：ROC分析将ANA阳性（ANA+）SLE（n = 91）与ARD，TIGG，BC4D和TC4D区分别表现出AUC值0.81、0.80和0.79，表现优于抗DSDNA（0.72），C3（0.69），Tigm（0.67），C4（0.61），（0.61），（0.66），（0.66），（0.66），（0.66），（0.66）和（0.66），（0.66）和（0.66）（0.66）（0.66）（0.66）（0.66）。在ROC分析中观察到了类似的歧视能力排名，区分ANA+ SLE与OD以及ANA+ SLE与AHV相似。 SLE与AHV的诊断特异性为95％，SLE的TC4D，TIGG和TIGM的敏感性（95％CI）为58.1％（48.1-67.7％），31.4％（22.7-41.7-41.2％）和29.5％（21.0-39.2％）。 T细胞SLE生物标志物唯一地鉴定出19％（20/105）的SLE患者，这些患者否则常规SLE自身抗体的阴性（血清学上）不活跃并且血清补体水平正常。在血清学非活性SLE子集中，T细胞SLE生物标志物共同识别了53％的受试者。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：新型的SLE生物标志物TC4D，TigG和Tigm在多个同类中始终超过常规标记。它们的整合增强了诊断敏感性，尤其是在SLE特异性自身抗体阴性患者中的敏感性。当与常规生物标志物结合使用时，这些新型测试可能会更早，更准确地检测，从而及时诊断和治疗。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40093011/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40093011</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11907206/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11907206</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1518208>10.3389/fimmu.2025.1518208</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40093011</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Vasileios Kyttaris</dc:creator><dc:creator>丹尼尔·J·华莱士（Daniel J Wallace）</dc:creator><dc:creator>阿雷佐·霍斯罗沙希（Arezou Khosroshahi）</dc:creator><dc:creator>安德鲁·康夫夫（Andrew Concoff）</dc:creator><dc:creator>妮可·威尔逊</dc:creator><dc:creator>Chau Ching Liu</dc:creator><dc:creator>苏珊·曼兹（Susan Manzi）</dc:creator><dc:creator>约瑟夫·艾尔恩（Joseph Ahearn）</dc:creator><dc:creator> Sepehr Taghavi</dc:creator><dc:creator>图巴·沃西（Touba Warsi）</dc:creator><dc:creator>斯坦利公园</dc:creator><dc:creator>克里斯汀·施莱夫（Christine Schleif）</dc:creator><dc:creator>布列塔尼·德（Brittany D）</dc:creator><dc:creator>泰勒·奥马利</dc:creator><dc:date>2025-03-17</dc:date><dc:source>免疫学领域</dc:source><dc:title>以多为中心的临床验证证明了狼疮诊断中的精度：T细胞自身抗体和TC4D的表现要优于常规狼疮红eRythematosus生物标志物</dc:title><dc:identifier>PMID：40093011</dc:identifier><dc:identifier> PMC：PMC11907206</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1518208</dc:identifier></item><item><title>重新定义组织损伤和修复中的CRP：不仅仅是急性促炎性介体</title><link/>https://pubmed.ncbi.nlm.nih.gov/40093010/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250317205223＆v = 2.18.0.post9+e462414<description>大多数早期研究研究了C反应蛋白（CRP）在组织损伤中的作用，确定其支持促炎和促炎活性。但是，这些发现并非普遍，因为其他数据建议CRP抑制了这些相同的过程。这些不同观察结果的潜在解释最终出现，即CRP经历了体内的上下文依赖性构象变化，其三种同工型（PCRP），修改了... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月28日； 16：1564607。 doi：10.3389/fimmu.2025.1564607。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">大多数早期研究研究了C反应蛋白（CRP）在组织损伤中的作用，确定其支持促炎和促炎活性。但是，这些发现并非普遍，因为其他数据建议CRP抑制了这些相同的过程。这些不同观察结果的潜在解释最终出现了，CRP承认<i>体内</i>依赖上下文依赖性构象变化，其三种同工型（PCRP），修饰的五型五体crp（PCRP*）和monomeric CRP（MCRP）（Monomeric CRP（MCRP））具有不同的效果。在这篇综述中，我们考虑了这种新的范式，并重新评估了CRP及其同工型在组织修复过程中的作用。实际上，越来越多的证据表明，不仅在止血和炎症中参与了CRP，而且还参与了炎症和组织再生的解决。此外，我们简要讨论了当前可用的CRP诊断测试的缺点，并强调了当前在临床实践中使用CRP的变化的需求。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40093010/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40093010</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11906453/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11906453</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1564607>10.3389/fimmu.2025.1564607</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40093010</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Marc Potempa</dc:creator><dc:creator>彼得·哈特</dc:creator><dc:creator>ibraheem m rajab</dc:creator><dc:creator>劳伦斯·波特姆帕</dc:creator><dc:date>2025-03-17</dc:date><dc:source>免疫学领域</dc:source><dc:title>重新定义组织损伤和修复中的CRP：不仅仅是急性促炎性介体</dc:title><dc:identifier>PMID：40093010</dc:identifier><dc:identifier> PMC：PMC11906453</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1564607</dc:identifier></item><item><title>骨桥的免疫双重性及其对肾脏移植的治疗意义</title><link/>https://pubmed.ncbi.nlm.nih.gov/40093009/?utm_source=chrome&amp;utm_medium = rsss＆utm_camp aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250317205223＆v = 2.18.0.post9+e462414<description>骨桥蛋白（OPN）是一种多功能糖蛋白，具有各种结构结构域，使其能够在生理和病理状态下执行多种功能。这篇综述从多个角度全面研究了OPN，包括其蛋白质结构，与受体的相互作用，与免疫细胞的相互作用以及在肾脏疾病中的作用和移植。这篇评论探讨了OPN的免疫二元性及其作为生物标志物和...的意义和价值</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月28日； 16：1520777。 doi：10.3389/fimmu.2025.1520777。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">骨桥蛋白（OPN）是一种多功能糖蛋白，具有各种结构结构域，使其能够在生理和病理状态下执行多种功能。这篇综述从多个角度全面研究了OPN，包括其蛋白质结构，与受体的相互作用，与免疫细胞的相互作用以及在肾脏疾病中的作用和移植。这篇综述探讨了OPN的免疫双重性及其作为肾移植中的生物标志物和治疗靶标的意义和价值。在癌症中，OPN通常通过抑制免疫系统来促进肿瘤逃避。相反，在免疫相关的肾脏疾病，尤其是肾脏移植中，OPN通过增强免疫细胞的迁移和激活来激活免疫系统，从而加剧肾脏损害。这种免疫二元性可能源于不同的OPN剪接变体，而在裂解后暴露于不同的结构结构域，这些结构结构域在细胞相互作用中起着不同的生物学作用。此外，OPN移植后和慢性肾脏疾病具有显着的生物学影响，并强调了其作为生物标志物和潜在治疗靶点的重要性。未来的研究应进一步探索肾脏移植中OPN的特定机制，以改善治疗策略并提高患者的生活质量。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40093009/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40093009</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11906708/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11906708</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1520777>10.3389/fimmu.2025.1520777</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40093009</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator>隆多·隆</dc:creator><dc:creator>Lei Qu</dc:creator><dc:creator> Qifa ye</dc:creator><dc:creator> Zibiao Zhong</dc:creator><dc:date> 2025-03-17</dc:date><dc:source>免疫学领域</dc:source><dc:title>骨桥的免疫双重性及其对肾脏移植的治疗意义</dc:title><dc:identifier>PMID：40093009</dc:identifier><dc:identifier> PMC：PMC11906708</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1520777</dc:identifier></item><item><title>超越CCR7：2型炎症中的树突状细胞迁移</title><link/>https://pubmed.ncbi.nlm.nih.gov/40093008/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250317205223＆v = 2.18.0.post9+e462414<description>常规的树突状细胞（CDC）是启动和调节T细胞反应的至关重要的抗原呈递细胞，从而塑造了针对病原体，无害抗原，肿瘤和自我抗原的免疫力。 CDC从外周组织迁移到排水淋巴结（DLN）对于它们在免疫监视中的功能至关重要。这种迁移使CDC可以将外围组织的条件传达给DLN中的抗原特异性T细胞，从而促进有效的免疫反应。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月28日； 16：1558228。 doi：10.3389/fimmu.2025.1558228。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">常规的树突状细胞（CDC）是启动和调节T细胞反应的至关重要的抗原呈递细胞，从而塑造了针对病原体，无害抗原，肿瘤和自我抗原的免疫力。 CDC从外周组织迁移到排水淋巴结（DLN）对于它们在免疫监视中的功能至关重要。这种迁移使CDC可以将外围组织的条件传达给DLN中的抗原特异性T细胞，从而促进有效的免疫反应。迁移主要是由趋化因子受体CCR7介导的，趋化因子受体CCR7响应于稳态和炎症提示，将CDC引导到DLNS。但是，在2型免疫反应（例如由寄生虫或过敏原触发的免疫反应）中，尽管CCR7表达较低，但悖论会出现悖论向DLN迁移。这篇综述讨论了2型炎症如何依赖于其他信号通路，包括膜衍生的生物活性脂质介质（如类eicosanoids，sphingolipids和oxysterols）诱导的信号传导途径，它们与CCR7合作以增强CDC迁移和T ​​Helper 2（TH2）分化。我们探讨了2型免疫中CDC迁移的潜在调节机制，从而有助于对不同免疫环境中CDC运输的差异控制及其对免疫反应的影响。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40093008/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40093008</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11906670/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11906670</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1558228>10.3389/fimmu.2025.1558228</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40093008</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator>奥黛丽·梅伦（Audrey Meloun）</dc:creator><dc:creator>比阿特丽斯·莱昂</dc:creator><dc:date>2025-03-17</dc:date><dc:source>免疫学领域</dc:source><dc:title>超越CCR7：2型炎症中的树突状细胞迁移</dc:title><dc:identifier>PMID：40093008</dc:identifier><dc:identifier> PMC：PMC11906670</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1558228</dc:identifier></item><item><title>病例报告：肌电连接酶4缺乏 - 免疫调节范式</title><link/>https://pubmed.ncbi.nlm.nih.gov/40093007/?utm_source=chrome&amp;utm_medium = rsss＆utm_camp aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250317205223＆v = 2.18.0.post9+e462414<description> DNA连接酶4对于非同源末端连接至关重要，对于T和B细胞发育中的V（d）J重组所必需的。连接酶4缺乏症是由DNA连接酶4基因中的肌肉小组突变引起的罕见常染色体隐性障碍，可以导致广泛的表型。我们描述了连接酶4缺乏症的病例，导致了一种TB-NK+非典型SCID，突出了临床和免疫学表现。一位来自圣尼古劳岛（Verde）的八岁女性，在... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月28日； 16：1545630。 doi：10.3389/fimmu.2025.1545630。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> DNA连接酶4对于非同源末端连接至关重要，对于T和B细胞发育中的V（d）J重组所必需的。连接酶4缺乏症是由DNA连接酶4基因中的肌肉小组突变引起的罕见常染色体隐性障碍，可以导致广泛的表型。我们描述了连接酶4缺乏症的病例，导致了一种TB-NK+非典型SCID，突出了临床和免疫学表现。来自圣尼古劳岛（Verde）的一名八岁女性在我们的医院出现，有复发性的肺炎和化脓性中耳炎的病史，自两岁以来，归因于真菌和细菌感染的多种皮肤病变，以及重复的时期性恐惧和生长障碍，开始于四岁。实验室检查显示几乎没有B细胞，明显的低磁性血症以及对蛋白质抗原的反应受损。流式细胞仪显示正常的NK和T细胞计数，但几乎没有幼稚的T细胞和表达T淋巴细胞的TCR-VA7，并且对有丝分裂剂和抗原的增殖反应降低。通过FACS鉴定了寡克隆Vβ曲目，Promidisa分析显示偏斜的TCRA曲目签名。 A 477与PID相关的基因NGS面板鉴定了DNA连接酶4基因中的纯合R278H突变，此前据报道会导致连接酶4缺乏症。在等待造血干细胞移植时开始了免疫球蛋白替代和预防性疗法。她经历了反式激酶水平波动。皮肤活检暗示着狼疮pernio。她的四肢表现出复发性的炎症体征，超声波检查中有记录的斜螺旋炎。连接酶4中的纯合R278H与连接酶4缺陷患者的各种表现范围有关。在我们的报告中，该基因型导致TB-NK+非典型SCID，在适当的预防后具有主要的自身免疫性表型。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40093007/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40093007</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11906410/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11906410</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1545630>10.3389/fimmu.2025.1545630</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40093007</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator>卡塔琳娜·安德拉德（Catarina Andrade）</dc:creator><dc:creator> Ana Isabel Cordeiro</dc:creator><dc:creator> Marta Valente Pinto</dc:creator><dc:creator> ConceiçãoNeves</dc:creator><dc:creator>卡塔琳娜·马丁斯</dc:creator><dc:creator>让·皮埃尔·维拉塔伊（Jean-Pierre Villartay）</dc:creator><dc:creator> JoãoFarelaNeves</dc:creator><dc:date> 2025-03-17</dc:date><dc:source>免疫学领域</dc:source><dc:title>病例报告：肌电连接酶4缺乏 - 免疫调节范式</dc:title><dc:identifier>PMID：40093007</dc:identifier><dc:identifier> PMC：PMC11906410</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1545630</dc:identifier></item><item><title>探索自身免疫性内分泌病的抗原变异</title><link/>https://pubmed.ncbi.nlm.nih.gov/40093006/?utm_source=chrome&amp;utm_medium = rsss＆utm_camp aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250317205223＆v = 2.18.0.post9+e462414<description>自身免疫性疾病由于对自我抗原的误导性反应而发展。遗传研究表明，编码免疫系统蛋白质的基因中的许多变异与自身免疫的发展有关。实际上，关键免疫受体或转录因子中的许多遗传变异在几种不同的自身免疫性条件的发病机理中很常见。相反，发展自身免疫的倾向是... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月28日； 16：1561455。 doi：10.3389/fimmu.2025.1561455。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">自身免疫性疾病由于对自我抗原的误导性反应而发展。遗传研究表明，编码免疫系统蛋白质的基因中的许多变异与自身免疫的发展有关。实际上，关键免疫受体或转录因子中的许多遗传变异在几种不同的自身免疫性条件的发病机理中很常见。相比之下，对任何特定的目标器官或组织开发自身免疫的倾向是不足的。这与自身免疫性内分泌条件特别相关，该条件是特定于器官的参与。编码自身免疫反应靶标的基因中的遗传多态性已被证明与几种自身免疫性疾病的易感性有关，包括1型糖尿病，自身免疫性甲状腺病和艾迪生氏病。从机械上讲，导致静脉表达，过表达，不同定位，替代剪接或翻译后修饰的变化可能会干扰耐受性诱导过程。这篇综述将总结某些编码内分泌特异性抗原的基因的遗传变异方式（INS，TSHR，TPO，CYP21A2，PIT-1）可能会倾向于不同的自身免疫内分泌条件。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40093006/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40093006</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11906412/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11906412</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1561455>10.3389/fimmu.2025.1561455</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40093006</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator>玛丽亚·马夫里杜（Maria Mavridou）</dc:creator><dc:creator>西蒙·皮尔斯（Simon H Pearce）</dc:creator><dc:date> 2025-03-17</dc:date><dc:source>免疫学领域</dc:source><dc:title>探索自身免疫性内分泌病的抗原变异</dc:title><dc:identifier>PMID：40093006</dc:identifier><dc:identifier> PMC：PMC11906412</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1561455</dc:identifier></item><item><title>膜蛋白免疫原构象表位的保存的进步</title><link/>https://pubmed.ncbi.nlm.nih.gov/40093005/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250317205223＆v = 2.18.0.post9+e462414<description>靶向天然膜蛋白的抗体提出了各种挑战，因为这些蛋白通常嵌入脂质双层中，具有各种细胞外和细胞内结构域，并且经过翻译后修饰。 MPS的这些特性使得在膜外保持其稳定的本地构象或抗体产生的稳定构象。此外，由于其跨膜区域，MPS通常是疏水的，使其成为... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月28日； 16：1538871。 doi：10.3389/fimmu.2025.1538871。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">靶向天然膜蛋白的抗体提出了各种挑战，因为这些蛋白通常嵌入脂质双层中，具有各种细胞外和细胞内结构域，并且经过翻译后修饰。 MPS的这些特性使得在膜外保持其稳定的本地构象或抗体产生的稳定构象。此外，由于其跨膜区域，MPS通常是疏水性的，因此难以以其天然形式溶解和净化。因此，采用纯化的MP进行免疫原制备可能会导致变性或天然结构的丧失，从而使它们不足地产生识别天然构象的抗体。尽管存在这些障碍，但仍出现了各种新方法来解决这些问题。我们概述了在设计和准备免疫原子以产生针对MP的抗体的最新进展。这里概述的策略与生产用于研究，诊断和疗法的抗体以及用于疫苗接种目的的免疫原子有关。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40093005/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40093005</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11906443/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11906443</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1538871>10.3389/fimmu.2025.1538871</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40093005</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Aisha Mahboob</dc:creator><dc:creator> Nishat Fatma</dc:creator><dc:creator>艾哈迈德·法拉兹（Ahmed Faraz）</dc:creator><dc:creator>蒙塔哈·佩尔维兹（Muntaha Pervez）</dc:creator><dc:creator>穆罕默德·阿菲夫·汗（Mohammad Afeef Khan）</dc:creator><dc:creator>阿夫扎尔·侯赛因</dc:creator><dc:date>2025-03-17</dc:date><dc:source>免疫学领域</dc:source><dc:title>膜蛋白免疫原构象表位的保存的进步</dc:title><dc:identifier>PMID：40093005</dc:identifier><dc:identifier> PMC：PMC11906443</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1538871</dc:identifier></item><item><title>社论：HIV-1的全球表型多样性：对发病机理，疫苗和治疗的影响</title><link/>https://pubmed.ncbi.nlm.nih.gov/40093004/?utm_source=Chrome&amp;utm_medium = rsss＆utm_camp aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250317205223＆v = 2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月28日； 16：1572732。 doi：10.3389/fimmu.2025.1572732。环保2025。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40093004/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40093004</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11906715/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11906715</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1572732>10.3389/fimmu.2025.1572732</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40093004</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Azam Bolhassani</dc:creator><dc:date> 2025-03-17</dc:date><dc:source>免疫学领域</dc:source><dc:title>社论：HIV-1的全球表型多样性：对发病机理，疫苗和治疗的影响</dc:title><dc:identifier>PMID：40093004</dc:identifier><dc:identifier> PMC：PMC11906715</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1572732</dc:identifier></item><item><title>在厄姆特甲滨 + tenofovir disoproxy fumarate + dotutegravir治疗开始之前和之后的恒河猕猴中的细胞外无水和道缺陷的调节和分布</title><link/>https://pubmed.ncbi.nlm.nih.gov/40093003/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250317205223＆v = 2.18.0.post9+e462414<description>简介：了解手推车启动的特定时机，其有效性和失败，并评估当前的手推车方案控制病毒复制和反弹，增强免疫功能以及修复或遏制中枢神经系统（CNS）的早期损伤对于改善HIV患者的生计至关重要。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月28日； 16：1463434。 doi：10.3389/fimmu.2025.1463434。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：了解手推车启动的特定时机，其有效性和失败，并评估当前的手推车方案控制病毒复制和反弹，增强免疫功能以及修复或遏制中枢神经系统（ <i>CNS</i> ）的早期损伤对于改善HIV患者的生计至关重要。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在这里，我们使用动物模型来提供受控的环境，以了解中国原状鼠猴的身体（免疫系统和<i>CNS</i> ）如何应对Emtricerabine（ <i>Emtbl/FTC</i> ），Dolutegravir（DTG）（DTG）（ <i>DTG</i> ）和Tenofovir fimoproxil fumarate（ <i>TDDF</i> ）的结合（tddf），以下是造成模拟（ <i>TDDF</i> ）的结合。我们通过臂静脉向恒河猴注入了<i>恒河猴</i>（即，IE，TCID50-A 50倍半组织培养感染剂量），并在基线，第35天，第35天，第84天，第168天，第252天，第252天，以及MRI 336的第336天的siss和血液/csf sass siss和血液/ <i>csf copies和siv copies copies和siv copies copies和siv</i> copies copies和siss copies copies and。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果与讨论：我们的实验数据表明，最早在感染后7天后将免疫系统损害， <i>ML</i>的<i>SIV</i>副本快速上升， <i>CD4/CD8</i>比在感染的前14天内显着下降至〜1以下。细胞外环境的改变，表现为MRI数据中的游离水量分数（ <i>FW -VF</i> ）增加，并且在<i>FW</i>验证的<i>FA</i>和<i>FW</i>验证的<i>MD</i>中出现的纤维组织的扩散性能的变化，并同时出现在脑部抗病系统中，这表明<i>脑部</i>的侵蚀是脑部的侵蚀，表明脑部的侵蚀性较早，这表明脑部的侵蚀是在早期的秘密范围内，这是在脑海中的早期侵蚀。影响<i>中枢神经系统</i>。我们的发现表明，我们当前的FTC + <i>TDF</i> + <i>DTG</i>方案可以增强免疫系统，抑制<i>SIV</i>复制，并对细胞内和细胞外环境造成缓慢的伤害。但是，在控制一些恒河猴的病毒反弹和经历的耐药性方面仍然无效，这可能会导致对<i>中枢神经系统</i>的进一步损害。我们的发现还提供了第一个基于SIVMAC239的证据，表明细胞外<i>FW-VF</i>可能是异常炎症过程更可靠的生物标志物，从而比以前预期的更好地了解<i>SIV</i>疾病进展。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40093003/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40093003</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11906442/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11906442</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1463434>10.3389/fimmu.2025.1463434</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40093003</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator>本笃会亚历山大·恩古胡（Alexander Nguchu）</dc:creator><dc:creator> lu</dc:creator><dc:creator> Yifei Han</dc:creator><dc:creator>杨王</dc:creator><dc:creator>Jiaojiao Liu</dc:creator><dc:creator> Hongjun li</dc:creator><dc:creator>彼得·肖</dc:creator><dc:date>2025-03-17</dc:date><dc:source>免疫学领域</dc:source><dc:title>在厄姆特甲滨 + tenofovir disoproxy fumarate + dotutegravir治疗开始之前和之后的恒河猕猴中的细胞外无水和道缺陷的调节和分布</dc:title><dc:identifier>PMID：40093003</dc:identifier><dc:identifier> PMC：PMC11906442</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1463434</dc:identifier></item><item><title>独特的微生物特征及其在复发性急性胰腺炎中的预测价值：5区16S rRNA基因测序的见解</title><link/>https://pubmed.ncbi.nlm.nih.gov/40093002/?utm_source=Chrome&amp;utm_medium = rsss&amp;utm_camp aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250317205223＆v = 2.18.0.post9+e462414<description>结论：本研究确定了与RAP相关的不同临床和微生物特征，强调了特定细菌分类群在胰腺炎复发中的作用。研究结果表明，微生物分析可以增强说唱的诊断和管理，为个性化的治疗方法铺平了道路。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月28日； 16：1558983。 doi：10.3389/fimmu.2025.1558983。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：复发性急性胰腺炎（RAP）提出了重大的临床挑战，在5年内为慢性胰腺炎发展了32.3％。导致RAP的基本微生物因素仍然知之甚少。这项研究旨在鉴定与RAP相关的血液微生物特征，并探索RAP的潜在微生物预测因子。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在此前瞻性队列中，根据胰腺炎发作的数量，将90名急性胰腺炎患者分为非急性急性胰腺炎（NRAP，n = 68）和RAP（N = 22）组。使用5区（5R）16S rRNA基因测序分析血液样品的微生物组成。进行关键的微生物分类单元和功能预测。随机森林模型用于评估RAP微生物特征的预测值。在实验小鼠模型中进一步评估了<i>hominis葡萄球菌（hominis）</i>对RAP的影响。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：线性判别分析效应大小（LEFSE）分析突出了明显的微生物差异，<i>氨基甲虫</i>，<i>葡萄糖核酸杆菌</i>和<i>hominis</i>在RAP中是突出的。功能预测表明RAP组代谢途径的富集。随机森林分析可确定关键的微生物分类单元，用于预测RAP的AUC值为0.759。实验验证表明， <i>hominis</i>会加剧小鼠的胰腺炎症。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：本研究确定了与RAP相关的不同临床和微生物特征，强调了特定细菌分类群在胰腺炎复发中的作用。研究结果表明，微生物分析可以增强说唱的诊断和管理，为个性化的治疗方法铺平了道路。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40093002/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40093002</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11906328/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11906328</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1558983>10.3389/fimmu.2025.1558983</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40093002</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Qi-Wen Wang</dc:creator><dc:creator> Haorui Zheng</dc:creator><dc:creator>杨阳</dc:creator><dc:creator>Xinyao Chang</dc:creator><dc:creator> Zengkan du</dc:creator><dc:creator> Zining挂起</dc:creator><dc:creator>Zhao-shen li</dc:creator><dc:creator> Zhuan Liao</dc:creator><dc:date> 2025-03-17</dc:date><dc:source>免疫学领域</dc:source><dc:title>独特的微生物特征及其在复发性急性胰腺炎中的预测价值：5区16S rRNA基因测序的见解</dc:title><dc:identifier>PMID：40093002</dc:identifier><dc:identifier> PMC：PMC11906328</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1558983</dc:identifier></item><item><title> &lt;em>; haemonchus contortus &lt;/em>; H11中保护性糖蛋白的识别和验证</title><link/>https://pubmed.ncbi.nlm.nih.gov/40093001/?utm_source=Chrome&amp;utm_medium = rsss＆utm_camp aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250317205223＆v = 2.18.0.post9+e462414<description> Barbervax是第一个也是唯一可保护动物免受Haemonchus contortus的疫苗 - 小型反刍动物最致病的寄生虫之一。 This vaccine contains a kind of native antigen called H11, a glycoprotein complex derived from integral gut of this parasite. Native H11 has been shown to induce high levels (72-95%) of protection, but single or two recombinant molecules of H11 are consistently unsuccessful. An increasing number of aminopeptidases related to H11 have been... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Front Immunol</b> . 2025 Feb 28;16:1521022. doi: 10.3389/fimmu.2025.1521022. eCollection 2025.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Barbervax is the first and only available vaccine to protect animals against <i>Haemonchus contortus</i> - one of the most pathogenic parasites of small ruminants. This vaccine contains a kind of native antigen called H11, a glycoprotein complex derived from integral gut of this parasite. Native H11 has been shown to induce high levels (72-95%) of protection, but single or two recombinant molecules of H11 are consistently unsuccessful. An increasing number of aminopeptidases related to H11 have been characterized in the past three decades, but little is known about which ones are the key contributors to protective immunity. Our recent work has revealed that the immunoprotective effect of H11 is primarily associated with its N-glycan moieties. To identify key immunoprotective glycoproteins derived from H11 antigen, we employed glycan-related protective IgG antibodies combined with LC-MS/MS analysis and identified five glycosylated H11 proteins: H11, H11-1, H11-2, H11-4, and H11-5. Subsequently, we utilized the baculovirus-insect cell expression system and successfully expressed four H11 recombinant proteins including rH11, rH11-1, rH11-2 and rH11-4, which demonstrated similar aminopeptidase activity and comparable high-mannose and di-fucosylated N-glycan structures to those found on native H11. Immunization of goats with a cocktail of four rH11s induced a 66.29% reduction ( <i>p</i> >; 0.05) in total worm burden and cumulative fecal egg counts. High level of anti-rH11s IgG which could inhibit <i>H. contortus</i> intestinal aminopeptidase activity and larval development. Collectively, our study identified glycoprotein antigens from H11 and assessed their protective efficacy of a recombinant cocktail expressed in insect cells. This work will provide valuable insights into further development of recombinant vaccines against parasitic nematodes.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40093001/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40093001</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11906660/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11906660</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1521022>10.3389/fimmu.2025.1521022</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40093001</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Hui Liu</dc:creator><dc:creator> Yao Zhang</dc:creator><dc:creator> Jiarui Li</dc:creator><dc:creator> Feng Liu</dc:creator><dc:creator> Lisha Ye</dc:creator><dc:creator> Xin Liu</dc:creator><dc:creator> Chunqun Wang</dc:creator><dc:creator> Min Hu</dc:creator><dc:date> 2025-03-17</dc:date><dc:source> Frontiers in immunology</dc:source><dc:title> Identification and validation of protective glycoproteins in &lt;em>;Haemonchus contortus&lt;/em>; H11</dc:title><dc:identifier> pmid:40093001</dc:identifier><dc:identifier> pmc:PMC11906660</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1521022</dc:identifier></item><item><title> Integration of scRNA-seq and bulk RNA-seq to reveal the association and potential molecular mechanisms of metabolic reprogramming regulated by lactylation and chemotherapy resistance in ovarian cancer</title><link/> https://pubmed.ncbi.nlm.nih.gov/40093000/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250317205223&amp;v=2.18.0.post9+e462414<description> CONCLUSION: This work elucidates the significant function of lactylation in OC chemoresistance and identifies ALDH1A1 and S100A4 as possible genes associated with drug resistance. These findings enhance our comprehension of the mechanisms behind chemoresistance in OC and offer critical insights for the formulation of novel therapeutic options. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Front Immunol</b> . 2025 Feb 28;16:1513806. doi: 10.3389/fimmu.2025.1513806. eCollection 2025.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> OBJECTIVE: Ovarian cancer (OC) ranks among the foremost causes of mortality in gynecological malignancies, with chemoresistance being the primary factor contributing to unfavorable prognosis. This work seeks to clarify the mechanisms of resistance-related lactylation in OC, intending to offer novel theoretical foundations and therapy strategies for addressing chemoresistance. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: Through the combined analysis of bulk RNA-seq and single-cell RNA-seq data, we initially found lactylation genes linked to chemoresistance. Subsequently, we employed differential expression analysis, survival analysis, enrichment analysis, and other methodologies to further investigate the roles and molecular mechanisms of these genes in tumor resistance. Ultimately, we investigated the differential expression of these genes in resistant and non-resistant tissues and cells via experimentation. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: We found two candidate genes associated with lactylation chemoresistance, ALDH1A1 and S100A4. Analysis of single-cell data indicated that tumor cells represent the primary cell subpopulation relevant to resistance studies. Subpopulation analysis indicated that several tumor cell subtypes were markedly linked to resistance, with elevated expression levels of ALDH1A1 and S100A4 in the resistant subpopulation, notably correlating with various immunological and metabolic pathways. Analysis of metabolic pathways indicated that oxidative phosphorylation and glycolysis activity was elevated in the resistant subpopulation, and lactic acid buildup was associated with chemoresistance. The investigation of the marker gene protein-protein interaction network in the resistant subgroup elucidated the intricate interactions among these genes. The expression levels of ALDH1A1 and S100A4 in the OC tissues of the platinum-resistant cohort were markedly elevated compared to the sensitive cohort, with a considerable rise in S100A4 expression observed in resistant OC cells, demonstrating co-localization with lactylation. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: This work elucidates the significant function of lactylation in OC chemoresistance and identifies ALDH1A1 and S100A4 as possible genes associated with drug resistance. These findings enhance our comprehension of the mechanisms behind chemoresistance in OC and offer critical insights for the formulation of novel therapeutic options.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40093000/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40093000</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11907005/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11907005</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1513806>10.3389/fimmu.2025.1513806</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40093000</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Fang Ren</dc:creator><dc:creator> Xiaoao Pang</dc:creator><dc:creator> Feng Jin</dc:creator><dc:creator> Nannan Luan</dc:creator><dc:creator> Houhua Guo</dc:creator><dc:creator> Liancheng Zhu</dc:creator><dc:date> 2025-03-17</dc:date><dc:source> Frontiers in immunology</dc:source><dc:title> Integration of scRNA-seq and bulk RNA-seq to reveal the association and potential molecular mechanisms of metabolic reprogramming regulated by lactylation and chemotherapy resistance in ovarian cancer</dc:title><dc:identifier> pmid:40093000</dc:identifier><dc:identifier> pmc:PMC11907005</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1513806</dc:identifier></item><item><title> The distinct functions of MIF in inflammatory cardiomyopathy</title><link/> https://pubmed.ncbi.nlm.nih.gov/40092999/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250317205223&amp;v=2.18.0.post9+e462414<description> The immune system plays a crucial role in cardiac homeostasis and disease, and the innate and adaptive immune systems can be beneficial or detrimental in cardiac injury. The pleiotropic proinflammatory cytokine macrophage migration inhibitory factor (MIF) is involved in the pathogenesis of many human disease conditions, including heart diseases and inflammatory cardiomyopathies. Inflammatory cardiomyopathies are frequently observed after microbial infection but can also be caused by systemic... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Front Immunol</b> . 2025 Feb 28;16:1544484. doi: 10.3389/fimmu.2025.1544484. eCollection 2025.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> The immune system plays a crucial role in cardiac homeostasis and disease, and the innate and adaptive immune systems can be beneficial or detrimental in cardiac injury. The pleiotropic proinflammatory cytokine macrophage migration inhibitory factor (MIF) is involved in the pathogenesis of many human disease conditions, including heart diseases and inflammatory cardiomyopathies. Inflammatory cardiomyopathies are frequently observed after microbial infection but can also be caused by systemic immune-mediated diseases, drugs, and toxic substances. Immune cells and MIF are implicated in many of these conditions and may affect progression of inflammatory cardiomyopathy (ICM) to myocardial remodeling and dilated cardiomyopathy (DCM). The potential for targeting MIF therapeutically in patients with inflammatory diseases is an active area of investigation. Here we review the current literature supporting the role(s) of MIF in ICM and cardiac dysfunction. We posit that future research to further elucidate the underlying functions of MIF in cardiac pathologies is warranted.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40092999/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40092999</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11906721/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11906721</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1544484>10.3389/fimmu.2025.1544484</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40092999</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Kyle R Pressley</dc:creator><dc:creator> Yashfa Naseem</dc:creator><dc:creator> Saisha Nalawade</dc:creator><dc:creator> Thomas G Forsthuber</dc:creator><dc:date> 2025-03-17</dc:date><dc:source> Frontiers in immunology</dc:source><dc:title> The distinct functions of MIF in inflammatory cardiomyopathy</dc:title><dc:identifier> pmid:40092999</dc:identifier><dc:identifier> pmc:PMC11906721</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1544484</dc:identifier></item><item><title> OnmiMHC: a machine learning solution for UCEC tumor vaccine development through enhanced peptide-MHC binding prediction</title><link/> https://pubmed.ncbi.nlm.nih.gov/40092998/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250317205223&amp;v=2.18.0.post9+e462414<description> The key roles of Major Histocompatibility Complex (MHC) Class I and II molecules in the immune system are well established. This study aims to develop a novel machine learning framework for predicting antigen peptide presentation by MHC Class I and II molecules. By integrating large-scale mass spectrometry data and other relevant data types, we present a prediction model OnmiMHC based on deep learning. We rigorously assessed its performance using an independent test set, OnmiMHC achieves a... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Front Immunol</b> . 2025 Feb 28;16:1550252. doi: 10.3389/fimmu.2025.1550252. eCollection 2025.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> The key roles of Major Histocompatibility Complex (MHC) Class I and II molecules in the immune system are well established. This study aims to develop a novel machine learning framework for predicting antigen peptide presentation by MHC Class I and II molecules. By integrating large-scale mass spectrometry data and other relevant data types, we present a prediction model OnmiMHC based on deep learning. We rigorously assessed its performance using an independent test set, OnmiMHC achieves a PR-AUC score of 0.854 and a TOP20%-PPV of 0.934 in the MHC-I task, which outperforms existing methods. Likewise, in the domain of MHC-II prediction, our model OnmiMHC exhibits a PR-AUC score of 0.606 and a TOP20%-PPV of 0.690, outperforming other baseline methods. These results demonstrate the superiority of our model OnmiMHC in accurately predicting peptide-MHC binding affinities across both MHC-I and MHC-II molecules. With its superior accuracy and predictive capability, our model not only excels in general predictive tasks but also achieves significant results in the prediction of neoantigens for specific cancer types. Particularly for Uterine Corpus Endometrial Carcinoma (UCEC), our model has successfully predicted neoantigens with a high binding probability to common human alleles. This discovery is of great significance for the development of personalized tumor vaccines targeting UCEC.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40092998/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">40092998</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11906482/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250317205223&v=2.18.0.post9+e462414">PMC11906482</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1550252>10.3389/fimmu.2025.1550252</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40092998</guid><pubDate> Mon, 17 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Fangfang Jian</dc:creator><dc:creator> Haihua Cai</dc:creator><dc:creator> Qushuo Chen</dc:creator><dc:creator> Xiaoyong Pan</dc:creator><dc:creator> Weiwei Feng</dc:creator><dc:creator> ye yuan</dc:creator><dc:date> 2025-03-17</dc:date><dc:source> Frontiers in immunology</dc:source><dc:title> OnmiMHC: a machine learning solution for UCEC tumor vaccine development through enhanced peptide-MHC binding prediction</dc:title><dc:identifier> pmid:40092998</dc:identifier><dc:identifier> pmc:PMC11906482</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1550252</dc:identifier></item></channel></rss>